Time course of the liver enhancement by a novel MR contrast agent 'AMI- 25'

Akihiro Tanimoto, Y. Yuasa, M. Izutsu, Y. Sato, S. Ohkawa, K. Hiramatsu

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Superparamagnetic iron oxide (SPIO; AMI-25 from Eiken Chemical Co.) have been known to offer excellent tumor-liver contrast in liver MR imaging by reducing the signal intensity only of the liver. To investigate the duration of liver signal decrease caused by AMI-25, 15 patients underwent MR imaging three times; before, 1 hour after, and at the different elapsed time after the drug administration (4-9 hours, 22-26 hours, and 47-49 hours). The liver darkness and the contribution of the drug to hepatic tumor detection were subjectively ranked and liver signal-to-noise ratio (SNR) and tumor-liver contrast-to-noise ratio (CNR) were obtained by the region of interest, and compared among groups with different elapsed time. Both liver darkness and SNR were maintained up to 4-9 hours after the drug administration, and both the contribution to the tumor detection and CNR showed the similar results. Our results show that effect of AMI-25 could be maintained at least several hours after the drug administration, lasting longer than previously thought.

Original languageEnglish
Pages (from-to)713-724
Number of pages12
JournalJapanese Pharmacology and Therapeutics
Volume22
Issue number1
Publication statusPublished - 1994

Fingerprint

Contrast Media
Liver
Darkness
Signal-To-Noise Ratio
Pharmaceutical Preparations
Noise
Neoplasms
ferumoxides

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology

Cite this

Tanimoto, A., Yuasa, Y., Izutsu, M., Sato, Y., Ohkawa, S., & Hiramatsu, K. (1994). Time course of the liver enhancement by a novel MR contrast agent 'AMI- 25'. Japanese Pharmacology and Therapeutics, 22(1), 713-724.

Time course of the liver enhancement by a novel MR contrast agent 'AMI- 25'. / Tanimoto, Akihiro; Yuasa, Y.; Izutsu, M.; Sato, Y.; Ohkawa, S.; Hiramatsu, K.

In: Japanese Pharmacology and Therapeutics, Vol. 22, No. 1, 1994, p. 713-724.

Research output: Contribution to journalArticle

Tanimoto, A, Yuasa, Y, Izutsu, M, Sato, Y, Ohkawa, S & Hiramatsu, K 1994, 'Time course of the liver enhancement by a novel MR contrast agent 'AMI- 25'', Japanese Pharmacology and Therapeutics, vol. 22, no. 1, pp. 713-724.
Tanimoto, Akihiro ; Yuasa, Y. ; Izutsu, M. ; Sato, Y. ; Ohkawa, S. ; Hiramatsu, K. / Time course of the liver enhancement by a novel MR contrast agent 'AMI- 25'. In: Japanese Pharmacology and Therapeutics. 1994 ; Vol. 22, No. 1. pp. 713-724.
@article{e9b7fc4cfa194900920db58c3641aac1,
title = "Time course of the liver enhancement by a novel MR contrast agent 'AMI- 25'",
abstract = "Superparamagnetic iron oxide (SPIO; AMI-25 from Eiken Chemical Co.) have been known to offer excellent tumor-liver contrast in liver MR imaging by reducing the signal intensity only of the liver. To investigate the duration of liver signal decrease caused by AMI-25, 15 patients underwent MR imaging three times; before, 1 hour after, and at the different elapsed time after the drug administration (4-9 hours, 22-26 hours, and 47-49 hours). The liver darkness and the contribution of the drug to hepatic tumor detection were subjectively ranked and liver signal-to-noise ratio (SNR) and tumor-liver contrast-to-noise ratio (CNR) were obtained by the region of interest, and compared among groups with different elapsed time. Both liver darkness and SNR were maintained up to 4-9 hours after the drug administration, and both the contribution to the tumor detection and CNR showed the similar results. Our results show that effect of AMI-25 could be maintained at least several hours after the drug administration, lasting longer than previously thought.",
author = "Akihiro Tanimoto and Y. Yuasa and M. Izutsu and Y. Sato and S. Ohkawa and K. Hiramatsu",
year = "1994",
language = "English",
volume = "22",
pages = "713--724",
journal = "Japanese Pharmacology and Therapeutics",
issn = "0386-3603",
publisher = "Life Science Publishing Co. Ltd",
number = "1",

}

TY - JOUR

T1 - Time course of the liver enhancement by a novel MR contrast agent 'AMI- 25'

AU - Tanimoto, Akihiro

AU - Yuasa, Y.

AU - Izutsu, M.

AU - Sato, Y.

AU - Ohkawa, S.

AU - Hiramatsu, K.

PY - 1994

Y1 - 1994

N2 - Superparamagnetic iron oxide (SPIO; AMI-25 from Eiken Chemical Co.) have been known to offer excellent tumor-liver contrast in liver MR imaging by reducing the signal intensity only of the liver. To investigate the duration of liver signal decrease caused by AMI-25, 15 patients underwent MR imaging three times; before, 1 hour after, and at the different elapsed time after the drug administration (4-9 hours, 22-26 hours, and 47-49 hours). The liver darkness and the contribution of the drug to hepatic tumor detection were subjectively ranked and liver signal-to-noise ratio (SNR) and tumor-liver contrast-to-noise ratio (CNR) were obtained by the region of interest, and compared among groups with different elapsed time. Both liver darkness and SNR were maintained up to 4-9 hours after the drug administration, and both the contribution to the tumor detection and CNR showed the similar results. Our results show that effect of AMI-25 could be maintained at least several hours after the drug administration, lasting longer than previously thought.

AB - Superparamagnetic iron oxide (SPIO; AMI-25 from Eiken Chemical Co.) have been known to offer excellent tumor-liver contrast in liver MR imaging by reducing the signal intensity only of the liver. To investigate the duration of liver signal decrease caused by AMI-25, 15 patients underwent MR imaging three times; before, 1 hour after, and at the different elapsed time after the drug administration (4-9 hours, 22-26 hours, and 47-49 hours). The liver darkness and the contribution of the drug to hepatic tumor detection were subjectively ranked and liver signal-to-noise ratio (SNR) and tumor-liver contrast-to-noise ratio (CNR) were obtained by the region of interest, and compared among groups with different elapsed time. Both liver darkness and SNR were maintained up to 4-9 hours after the drug administration, and both the contribution to the tumor detection and CNR showed the similar results. Our results show that effect of AMI-25 could be maintained at least several hours after the drug administration, lasting longer than previously thought.

UR - http://www.scopus.com/inward/record.url?scp=0028107665&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028107665&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0028107665

VL - 22

SP - 713

EP - 724

JO - Japanese Pharmacology and Therapeutics

JF - Japanese Pharmacology and Therapeutics

SN - 0386-3603

IS - 1

ER -